Question 1

Who owns CNSP?

Accepted Answer

CNS PHARMACEUTICALS INC (CNSP) is held by 5 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is GEODE CAPITAL MANAGEMENT, LLC as of Q1 2026.

Question 2

Are institutions buying or selling CNSP?

Accepted Answer

In Q1 2026, 3 institutions opened or increased positions in CNS PHARMACEUTICALS INC while 1 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on CNSP?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for CNS PHARMACEUTICALS INC.

Question 4

How many hedge funds hold CNSP?

Accepted Answer

5 institutional investors report holding CNS PHARMACEUTICALS INC (CNSP) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into CNSP?

Accepted Answer

As of Q1 2026, tracked institutions in CNS PHARMACEUTICALS INC show 3 buyers versus 1 sellers — net inflows.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
GEODE CAPITAL MANAGEMENT, LLC	New	23,189	$55,653	0.0%	+69.74%	32
UBS Group AG	Increased	729(+19.3%)	$1,742	0.0%	-91.87%	9
MAI Capital Management	Unchanged	3	$8	0.0%	-92.39%	0
CITIGROUP INC	New	1	$2	0.0%	+69.74%	17
DANSKE BANK A/S	Unchanged	1	$2	0.0%	-41.96%	0
BANK OF AMERICA CORP /DE/	Exited	0(-100.0%)	$21	0.0%	-85.57%	0

CNS PHARMACEUTICALS INC

Continue exploring

Other Healthcare stocks held by institutions